SWP
GNOM icon

Stratos Wealth Partners’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Stratos Wealth Partners’s Portfolio GNOM Stock Details GNOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$832K Buy
14,645
+30
+0.2% +$1.43K 0.01% 924
2026
Q1 		$639K Sell
14,615
-125
-0.8% -$5.78K 0.01% 968
2025
Q4 		$670K Buy
14,740
+158
+1% +$7K 0.01% 921
2025
Q3 		$566K Buy
14,582
+193
+1% +$6.99K 0.01% 964
2025
Q2 		$485K Sell
14,389
-1,157
-7% -$36.6K 0.01% 943
2025
Q1 		$494K Buy
15,546
+150
+1% +$5.69K 0.01% 889
2024
Q4 		$598K Sell
15,396
-2,520
-14% -$106K 0.01% 862
2024
Q3 		$806K Sell
17,916
-2,294
-11% -$103K 0.01% 761
2024
Q2 		$844K Buy
20,210
+1,857
+10% +$77.6K 0.01% 710
2024
Q1 		$835K Buy
18,353
+7,099
+63% +$323K 0.01% 708
2023
Q4 		$520K Buy
11,254
+1,504
+15% +$61.3K 0.01% 866
2023
Q3 		$397K Buy
9,750
+831
+9% +$37.8K 0.01% 908
2023
Q2 		$432K Buy
8,919
+1,802
+25% +$90.1K 0.01% 822
2023
Q1 		$351K Buy
7,117
+808
+13% +$41.6K 0.01% 814
2022
Q4 		$319K Buy
6,309
+75
+1% +$3.87K 0.01% 869
2022
Q3 		$313K Buy
6,234
+716
+13% +$40.4K 0.01% 843
2022
Q2 		$270K Buy
5,518
+1,962
+55% +$99.5K 0.01% 971
2022
Q1 		$214K Buy
+3,556
New +$224K ﹤0.01% 1137

Other funds holding GNOM

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return
CFD
Creative Financial Designs Kokomo, Indiana $2.1B AUM 23.1% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
FIA
Foundations Investment Advisors Phoenix, Arizona $9.72B AUM 29.41% 1-Year Est. Return
SH
SLT Holdings Scottsdale, Arizona $160M AUM 52.3% 1-Year Est. Return

Stratos Wealth Partners's GNOM Position: Q2 2026 in Review

Stratos Wealth Partners increased its Global X Genomics & Biotechnology ETF (GNOM) stake by 0.21% in Q2 2026, buying an estimated $1.43K and bringing the position to 14,645 shares worth $832K. The position accounts for 0.01% of the portfolio, ranked #924.

Stratos Wealth Partners first reported a position in GNOM in Q1 2022 and has held it in 18 quarters since. The position peaked at $844K in Q2 2024. 48 funds tracked by Wall St. Rank hold GNOM as of Q2 2026.

  • Stratos Wealth Partners held 14,645 shares of Global X Genomics & Biotechnology ETF worth $832K as of Q2 2026.
  • Stratos Wealth Partners bought 30 Global X Genomics & Biotechnology ETF shares in Q2 2026, an estimated $1.43K.
  • Global X Genomics & Biotechnology ETF made up 0.01% of Stratos Wealth Partners's portfolio in Q2 2026, its #924 holding.
  • Stratos Wealth Partners first reported a position in Global X Genomics & Biotechnology ETF in Q1 2022 and has held it in 18 quarters since.
  • Stratos Wealth Partners's Global X Genomics & Biotechnology ETF position peaked at $844K in Q2 2024.
  • 48 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q2 2026.

Based on Stratos Wealth Partners's 13F filing for Q2 2026, filed 11 Aug 2026.